Expression of BCL10 in cervical cancer has a role in the regulation of cell growth through the activation of NF-κB-dependent cyclin D1 signaling

Gynecologic Oncology

Volumn 126, Issue 2, 2012, Pages 245-251

  Kuo, Sung Hsin ^a,b   Chou, Chia Hung ^a   Cheng, Ann Lii ^a,b   Wang, Chun Wei ^a,b   Chen, Yu Hsuan ^a,b   Chen, Ruey Jien ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

BCL10; Cell cycle; Cervical cancer; Cyclin D1; NF B

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN D1; DNA; I KAPPA B; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; PROTEIN BCL 10; SMALL INTERFERING RNA;

ADULT; ARTICLE; CARCINOGENESIS; CARCINOMA IN SITU; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; DNA BINDING; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; UTERINE CERVIX CANCER; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL CULTURE TECHNIQUES; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CYCLIN D1; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; NF-KAPPA B; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION; UTERINE CERVICAL NEOPLASMS;

EID: 84862897751     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.04.047     Document Type: Article

References (26)

1. Willis TG, Jadayel DM, Du MQ, Peng H, Perry AR, Abdul-Rauf M, et al. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 1999;96:35-45. (Pubitemid 29044151)
2. Zhang Q, Siebert R, Yan M, Hinzmann B, Cui X, Xue L, et al. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat Genet 1999;22:63-8. (Pubitemid 29214806)
3. Gaide O, Favier B, Legler DF, Bonnet D, Brissoni B, Valitutti S, et al. CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-kappa B activation. Nat Immunol 2002;3:836-43.
4. Newton K, Dixit VM. Mice lacking the CARD of CARMA1 exhibit defective B lymphocyte development and impaired proliferation of their B and T lymphocytes. Curr Biol 2003;13:1247-51. (Pubitemid 36872949)
5. Jun JE, Wilson LE, Vinuesa CG, Lesage S, Blery M, Miosge LA, et al. Identifying the MAGUK protein Carma-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis. Immunity 2003;18:751-62. (Pubitemid 36776425)
6. Petro JB, Rahman SM, Ballard DW, Khan WN. Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement. J Exp Med 2000;191:1745-54.
7. Holzmann K, Kohlhammer H, Schwaenen C, Wessendorf S, Kestler HA, Schwoerer A, et al. Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes. Cancer Res 2004;64:4428-33. (Pubitemid 38856913)
8. Yeh PY, Kuo SH, Yeh KH, Chuang SE, Hsu CH, Chang WC, et al. A pathway for tumor necrosis factor-alpha-induced Bcl10 nuclear translocation. Bcl10 is up-regulated by NF-kappaB and phosphorylated by Akt1 and then complexes with Bcl3 to enter the nucleus. J Biol Chem 2006;281:167-75. (Pubitemid 43671175)
9. James MA, Lee JH, Klingelhutz AJ. Human papillomavirus type 16 E6 activates NF-kappaB, induces cIAP-2 expression, and protects against apoptosis in a PDZ binding motif-dependent manner. J Virol 2006;80:5301-7.
10. Kutuk O, Basaga H. Aspirin inhibits TNFalpha- and IL-1-induced NF-kappaB activation and sensitizes HeLa cells to apoptosis. Cytokine 2004;25:229-37. (Pubitemid 38229414)
11. Nair A, Venkatraman M, Maliekal TT, Nair B, Karunagaran D. NF-kappaB is constitutively activated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix. Oncogene 2003;22:50-8. (Pubitemid 36152883)
12. Li J, Jia H, Xie L, Wang X, Wang X, He H, et al. Association of constitutive nuclear factor-kappaB activation with aggressive aspects and poor prognosis in cervical cancer. Int J Gynecol Cancer 2009;19:1421-6.
13. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006;441:431-6. (Pubitemid 44050137)
14. Guttridge DC, Albanese C, Reuther JY, Pestell RG, Baldwin Jr AS. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 1999;19:5785-99. (Pubitemid 29339933)
15. Vermeulen K, Van Bockstaele DR, Berneman ZN. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 2003;36:131-49. (Pubitemid 36808270)
16. Kuo SH, Hsu CH, Chen LT, Lu YS, Lin CH, Yeh PY, et al. Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001. Eur J Cancer 2011;47:1244-57.
17. Kuo SH, Yeh PY, Chen LT, Wu MS, Lin CW, Yeh KH, et al. Overexpression of B cell-activating factor of TNF family (BAFF) is associated with Helicobacter pylori-independent growth of gastric diffuse large B-cell lymphoma with histologic evidence of MALT lymphoma. Blood 2008;112:2927-34.
18. Kuo SH, Chen LT, Yeh KH, Wu MS, Hsu HC, Yeh PY, et al. Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas. J Clin Oncol 2004;22:3491-7.
19. Vejabhuti C, Harris GJ, Erickson BA, Nishino H, Chevez-Barrios P, Chang CC. BCL10 expression in ocular adnexal lymphomas. Am J Ophthalmol 2005;140:836-43.
20. Ye H, Dogan A, Karran L, Willis TG, Chen L, Wlodarska I, et al. BCL10 expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphoma. Am J Pathol 2000;157:1147-54.
21. Chang HH, Kuo MY, Cheng SJ, Chiang CP. Expression of BCL10 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. Oral Oncol 2009;45:589-93.
22. Garg AK, Jhingran A, Klopp AH, Aggarwal BB, Kunnumakkara AB, Broadus RR, et al. Expression of nuclear transcription factor kappa B in locally advanced human cervical cancer treated with definitive chemoradiation. Int J Radiat Oncol Biol Phys 2010;78:1331-6.
23. Bae DS, Cho SB, Kim YJ, Whang JD, Song SY, Park CS, et al. Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus. Gynecol Oncol 2001;81:341-7.
24. Bahnassy AA, Zekri AR, Saleh M, Lotayef M, Moneir M, Shawki O. The possible role of cell cycle regulators in multistep process of HPV-associated cervical carcinoma. BMC Clin Pathol 2007;7:4.
25. Nichols GE, Williams ME, Gaffey MJ, Stoler MH. Cyclin D1 gene expression in human cervical neoplasia. Mod Pathol 1996;9:418-25. (Pubitemid 26153384)
26. Vijayalakshmi N, Selvaluxmi G, Majhi U, Rajkumar T. Alterations found in pl6/Rb/cyclin D1 pathway in the dysplastic and malignant cervical epithelium. Oncol Res 2007;16:527-33. (Pubitemid 351211325)